Role of vascular endothelial growth factor in Physiologic and Pathologic angiogenesis: Therapeutic implications

被引：658

作者：

Ferrara, N ^{[1
]}

机构：

[1] Genentech Inc, San Francisco, CA 94080 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 06期

关键词：

D O I：

10.1053/sonc.2002.37264

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

收藏

页码：10 / 14

页数：5

相关论文

共 34 条

[1]

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) [J].

Achen, MG ;

Jeltsch, M ;

Kukk, E ;

Mäkinen, T ;

Vitali, A ;

Wilks, AF ;

Alitalo, K ;

Stacker, SA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :548-553

[2]

SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS [J].

AIELLO, LP ;

PIERCE, EA ;

FOLEY, ED ;

TAKAGI, H ;

CHEN, H ;

RIDDLE, L ;

FERRARA, N ;

KING, GL ;

SMITH, LEH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10457-10461

[3]

Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].

Barleon, B ;

Sozzani, S ;

Zhou, D ;

Weich, HA ;

Mantovani, A ;

Marme, D .

BLOOD, 1996, 87 (08) :3336-3343

[4]

Borgström P, 1998, PROSTATE, V35, P1

[5]

Borgström P, 1999, ANTICANCER RES, V19, P4203

[6]

Borgstrom P, 1996, CANCER RES, V56, P4032

[7]

The vascular endothelial growth factor receptor Flt-1 mediates biological activities - Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis [J].

Clauss, M ;

Weich, H ;

Breier, G ;

Knies, U ;

Rockl, W ;

Waltenberger, J ;

Risau, W .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) :17629-17634

[8]

The vesiculo-vacuolar organelle (VVO): A new endothelial cell permeability organelle [J].

Dvorak, AM ;

Feng, D .

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2001, 49 (04) :419-431

[9]

VEGF: an update on biological and therapeutic aspects [J].

Farrara, N .

CURRENT OPINION IN BIOTECHNOLOGY, 2000, 11 (06) :617-624

[10]

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J].

Ferrara, N ;

CarverMoore, K ;

Chen, H ;

Dowd, M ;

Lu, L ;

OShea, KS ;

PowellBraxton, L ;

Hillan, KJ ;

Moore, MW .

NATURE, 1996, 380 (6573) :439-442

← 1 2 3 4 →